top of page
abstract render of neural structure

OUR MISSION

Lario Therapeutics exist to change the life of patients with severe neurological disorders by developing novel precision medicines for epileptic conditions and Parkinson’s disease.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

TEAM

Henning Steinhagen, PhD, MBA

Henning Steinhagen, PhD, MBA

Co-founder & CEO

Tom Otis, PhD

Tom Otis, PhD

CSO

Daniel Gill

Daniel Gill

Co-founder &
Head of Project Management

Paolo Pevarello, PhD

Paolo Pevarello, PhD

Head of Chemistry

Heidrun Potschka, PhD

Heidrun Potschka, PhD

Head of Epilepsy Pharmacology

Timothy Schulz-Utermoehl, PhD

Timothy Schulz-Utermoehl, PhD

Head of DMPK

Tim Hammond, PhD

Tim Hammond, PhD

Head of Safety

Richard Brooks, CA

Richard Brooks, CA

Financial Director

SCIENTIFIC ADVISORY BOARD

BOARD OF DIRECTORS

Peter Finan PhD

Peter Finan PhD

Investor Director, Epidarex

Chiara Liberati, PhD

Chiara Liberati, PhD

Investor Director, Golgi Neuroscience

Henning Steinhagen, PhD, MBA

Henning Steinhagen, PhD, MBA

Co-founder & CEO

bottom of page